Monthly Prescribing Reference (registration) |
LAMA LABA Uncontrolled Asthma ICS
Monthly Prescribing Reference (registration) Long-acting muscarinic antagonists (LAMA) have been shown to reduce exacerbations of chronic obstructive pulmonary disease (COPD) and are now being considered for patients with uncontrolled asthma as add-on treatment. A review in the Cochrane … |
View full post on asthma – Google News